Jing L. Marantz is Director of Arcturus Therapeutics Holdings Inc.. Currently has a direct ownership of 3,131 shares of ARCT, which is worth approximately $51,692. The most recent transaction as insider was on Jun 14, 2024, when has been sold 3,131 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.13K
0% 3M change
n/a 12M change
Total Value Held $51,692

Jing L. Marantz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2024
BUY
Exercise of conversion of derivative security
-
3,131 Added 50.0%
3,131 Common Stock

Also insider at

KRYS
Krystal Biotech, Inc. Healthcare
SRRK
Scholar Rock Holding Corp Healthcare
JLM

Jing L. Marantz

Director
Pittsburgh, PA

Track Institutional and Insider Activities on ARCT

Follow Arcturus Therapeutics Holdings Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARCT shares.

Notify only if

Insider Trading

Get notified when an Arcturus Therapeutics Holdings Inc. insider buys or sells ARCT shares.

Notify only if

News

Receive news related to Arcturus Therapeutics Holdings Inc.

Track Activities on ARCT